I thank Kritharides and colleagues1 for their review Cardiovascular disease in patients with schizophrenia. I agree with them and support their work, which seeks to improve the physical health of patients living in the community with a chronic mental illness such as schizophrenia, through an innovative, coordinated and multidisciplinary model of care. Clozapine side effects, including risks of myocarditis and cardiomyopathy, hypercholesterolaemia and weight gain, reduce years of life and require medical attention.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. Kritharides L, Chow V, Lambert TJR. Cardiovascular disease in patients with schizophrenia. Med J Aust 2017; 206: 91-95. <MJA full text>
- 2. NSW Agency for Clinical Innovation. Rehabilitation resources [website]. Sydney: ACI; 2017. https://www.aci.health.nsw.gov.au/resources/rehabilitation (accessed July 2017).
No relevant disclosures.